Shenlian Biomedical is a high-tech enterprise specializing in the R&D, production, and sales of veterinary biological products. Its main business covers FMD (foot-and-mouth disease) vaccines and veterinary diagnostic products. As a designated FMD vaccine production enterprise by the Ministry of Agriculture and Rural Affairs, Shenlian Biomedical took the lead in developing and mass-producing FMD synthetic peptide vaccines globally and is one of the pioneers in this field in China. The company is committed to building a world class high-tech biological enterprise. Since 2017, Wellthinic Technology has established a long-term strategic partnership with Shenlian Biomedical, continuously helping it build a one-stop intelligent control system and promoting the enterprise's digital transformation.
Solution Description:
Taking PCS7 and BATCH as the core control system, through the transplantation of long-accumulated module functions and the replication of successful experiences, it realizes refined production management and efficiently integrates third party process equipment to ensure seamless connection and coordinated operation between control and process equipment. Adopting a flexible modular design, combined with technical measures such as redundant configuration and flame-retardant shielded cables, it further improves the system's safety and reliability and reduces accident risks. Based on the GAMP5 validation guideline, it ensures compliance and stability, providing a solid support for the whole factory digital management and control and enabling the production process to be more efficient, standardized, and intelligent.
Implementation Effect:
Reduces unnecessary human intervention by 30%
The automation rate of workshop equipment operation is over 90%
Helps to achieve the goals of 100% product qualification rate and 100% supervision and random inspection qualification rate
Since its operation, the failure rate of the process production link is 0
Cooperative Projects and History:
2017 – 2018, PAS Phase I for the Lanzhou FMD Vaccine Project
2019, PAS Phase II for the Lanzhou FMD Vaccine Project
2021, Production Workshop Bioreactor Renovation Project
2022 – 2023, Whole Factory Automation Control System for the Vaccine Workshop
2024 – Present, Whole Factory Automation Control System for the mRNA Vaccine Workshop
